|
|
Volumn 88, Issue 4, 2004, Pages 837-846
|
|
The metabolic syndrome
a,b,c
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
2,4 THIAZOLIDINEDIONE DERIVATIVE;
ALDOSTERONE ANTAGONIST;
ANGIOTENSIN RECEPTOR ANTAGONIST;
ATENOLOL;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CALCIUM CHANNEL BLOCKING AGENT;
CAPTOPRIL;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
FELODIPINE;
FENOFIBRATE;
GEMFIBROZIL;
HIGH DENSITY LIPOPROTEIN CHOLESTEROL;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
LOW DENSITY LIPOPROTEIN CHOLESTEROL;
METFORMIN;
MEVINOLIN;
NICOTINIC ACID;
POTASSIUM CHANNEL BLOCKING AGENT;
PRAVASTATIN;
RAMIPRIL;
ROSIGLITAZONE;
SIMVASTATIN;
TETRAHYDROLIPSTATIN;
THIAZIDE DIURETIC AGENT;
ATHEROSCLEROSIS;
CALORIC RESTRICTION;
CARBOHYDRATE INTOLERANCE;
CARDIOVASCULAR RISK;
CLINICAL TRIAL;
DIABETIC HYPERTENSION;
DIAGNOSTIC ACCURACY;
DIET;
DISEASE COURSE;
DRUG BLOOD LEVEL;
DYSLIPIDEMIA;
ESSENTIAL HYPERTENSION;
EXERCISE;
GLUCOSE BLOOD LEVEL;
GLUCOSE TOLERANCE;
HUMAN;
HYPERGLYCEMIA;
HYPERTRIGLYCERIDEMIA;
INSULIN RESISTANCE;
LIFESTYLE;
METABOLIC SYNDROME X;
MORTALITY;
NON INSULIN DEPENDENT DIABETES MELLITUS;
OBESITY;
PREVALENCE;
PRIORITY JOURNAL;
REVIEW;
RISK ASSESSMENT;
RISK FACTOR;
SEX RATIO;
WEIGHT REDUCTION;
ADULT;
AGE DISTRIBUTION;
AGED;
CARDIOVASCULAR DISEASES;
COMBINED MODALITY THERAPY;
FEMALE;
HUMANS;
HYPERLIPIDEMIAS;
INCIDENCE;
INSULIN RESISTANCE;
MALE;
METABOLIC SYNDROME X;
MIDDLE AGED;
OBESITY;
PROGNOSIS;
RISK ASSESSMENT;
SEVERITY OF ILLNESS INDEX;
SEX DISTRIBUTION;
UNITED STATES;
|
|
EID: 4143151941
PISSN: 00257125
EISSN: None
Source Type: Journal
DOI: 10.1016/j.mcna.2004.04.001 Document Type: Review |
|
Times cited : (41)
|
|
References (6)
|
